Who has invested in AIRNA?

ARCH Venture Partners are named among the investors backing AIRNA.

AIRNA Funding: $215M Raised, Series B (2025)

AIRNA funding overview

AIRNA is a Biotech company based in San Francisco, California. AIRNA has raised $215M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in April 2025. The round record for AIRNA runs through 2025; nothing later has been disclosed. Investors on record include ARCH Venture Partners.

AIRNA at a glance

Total raised: $215M
Latest round: Series B
Latest round date: April 2025
Industry: Biotech
Headquarters: San Francisco, California
Notable investors: ARCH Venture Partners

Frequently asked about AIRNA funding

How much has AIRNA raised?: AIRNA has raised $215M in total disclosed funding across the rounds on record.
Who has invested in AIRNA?: ARCH Venture Partners are named among the investors backing AIRNA.
What was the latest AIRNA funding round?: The most recent disclosed round is a Series B, announced in April 2025.
Where is AIRNA based?: AIRNA is based in San Francisco, California.
What sector does AIRNA operate in?: AIRNA is tracked under Biotech from San Francisco, California, with $215M in disclosed funding.
When did AIRNA last raise?: The last disclosed AIRNA round closed in April 2025 at Series B.

We update the AIRNA record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in San Francisco and their backers are listed below.

AIRNA Funding: $215M Raised, Series B (2025)

AIRNA funding overview

AIRNA at a glance

Frequently asked about AIRNA funding

AIRNA founders (1)

Companies related to AIRNA (40)

Browse related funding lists (5)